Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-06 Purchase |
2021-12-07 08:30 am |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
5,000 | $0.9403 | $4,702 | 151,500 (Direct) |
View |
| 2021-11-19 Purchase |
2021-11-22 08:47 am |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
4,500 | $1.1537 | $5,192 | 146,500 (Direct) |
View |
| 2020-08-24 Purchase |
2020-08-25 7:11 pm |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
142,000 | $2.04 | $289,680 | 142,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-29 Option Award |
2023-03-31 7:28 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer |
16,467 | $0 | 61,451 (Direct) |
View |
| 2023-03-29 Option Award |
2023-03-31 7:28 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
6,067 | $0 | 28,768 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-04 4:02 pm |
N/A 2022-12-30 |
CNS Pharmaceuticals Inc. | CNSP | Charles Faith L. Director |
3,500 | $0 | 3,500 (Direct) |
View |
| 2022-04-28 Option Award |
2022-04-29 5:12 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
250,000 | $0 | 681,000 (Direct) |
View |
| 2022-04-28 Option Award |
2022-04-29 5:11 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer |
600,000 | $0 | 1,349,500 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-14 09:40 am |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
33,000 | $0.31 | 184,500 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-09 2:34 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Keyes Jeffry R. Director |
11,100 | $0.2968 | 11,100 (Direct) |
View |
| 2022-03-08 Option Award |
2022-03-09 2:34 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
3,750 | $0.268 | 3,750 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-08 08:30 am |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer |
35,000 | $0.281 | 940,298 (Direct) |
View |
| 2020-05-05 Other |
2022-01-25 4:05 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Priebe Waldemar 10% Owner |
1,495,867 | $0 | 9,029,000 (Indirect) |
View |
| 2021-11-16 Option Award |
2021-11-18 8:07 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer |
5,000 | $1.28 | 905,298 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-16 5:00 pm |
N/A 2031-07-15 |
CNS Pharmaceuticals Inc. | CNSP | Andraczke Andrzej Director |
32,000 | $0 | 178,559 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-16 5:00 pm |
N/A 2031-07-15 |
CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director |
32,000 | $0 | 178,559 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-16 5:00 pm |
N/A 2031-07-15 |
CNS Pharmaceuticals Inc. | CNSP | Keyes Jeffry R. Director |
32,000 | $0 | 178,559 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-16 5:00 pm |
N/A 2031-07-15 |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
32,000 | $0 | 178,559 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 5:00 pm |
N/A 2031-02-05 |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
131,000 | $0 | 431,000 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 5:00 pm |
N/A 2031-02-05 |
CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer |
310,000 | $0 | 749,500 (Direct) |
View |
| 2020-06-12 Option Award |
2020-06-16 5:23 pm |
N/A 2030-06-12 |
CNS Pharmaceuticals Inc. | CNSP | Keyes Jeffry R. Director |
46,559 | $0 | 146,559 (Direct) |
View |
| 2020-06-12 Option Award |
2020-06-16 5:23 pm |
N/A 2030-06-12 |
CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director |
46,559 | $0 | 146,559 (Direct) |
View |
| 2020-06-12 Option Award |
2020-06-16 5:23 pm |
N/A 2030-06-12 |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
46,559 | $0 | 146,559 (Direct) |
View |
| 2020-06-12 Option Award |
2020-06-16 5:22 pm |
N/A 2030-06-12 |
CNS Pharmaceuticals Inc. | CNSP | Andraczke Andrzej Director |
46,559 | $0 | 146,559 (Direct) |
View |